The Petri Dish: uniQure sells Lexington site; Sanofi backs Watertown biotech The Business JournalsGenezen buys Lexington gene therapy plant from uniQure BioProcess InsiderGenezen To Acquire UniQure’s Commercial Gene Therapy Operations In Lexington Contract PharmaBlackRock shares maintain Buy rating on acquisition plans announcement By Investing.com Investing.com
Read More…
Source: https://www.bizjournals.com/boston/news/2024/07/05/petri-dish-uniqure-alkeus.amp.html